論文

査読有り
2018年5月1日

Tumor lysis syndrome associated with docetaxel and carboplatin in a case with recurrent endometrial cancer

Gynecologic Oncology Reports
  • Tomomichi Ito
  • ,
  • Tsuyoshi Ohta
  • ,
  • Megumi Narumi
  • ,
  • Hirotsugu Sakaki
  • ,
  • Manabu Seino
  • ,
  • Takeshi Sudo
  • ,
  • Satoru Nagase

24
開始ページ
21
終了ページ
23
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.gore.2018.02.005
出版者・発行元
Elsevier B.V.

Tumor lysis syndrome (TLS) is an oncological life-threatening complication characterized by hyperuricemia, hyperphosphatemia, and hyperkalemia, which can lead to acute renal failure, cardiac arrhythmias, cardiac arrest and seizures. Although TLS is a rare complication in patients with non-hematological malignancy, the mortality rate of TLS in solid tumors is higher than that in hematological malignancies. Acute renal injury is the most common cause of mortality associated with TLS in solid tumors. We report a case of TLS following chemotherapy for a recurrent uterine serous carcinoma. In this case, we speculated that the cause of death might be a pulmonary tumor embolism caused by TLS.

リンク情報
DOI
https://doi.org/10.1016/j.gore.2018.02.005
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/29845102
ID情報
  • DOI : 10.1016/j.gore.2018.02.005
  • ISSN : 2352-5789
  • PubMed ID : 29845102
  • SCOPUS ID : 85042681557

エクスポート
BibTeX RIS